NEVRO CORP's ticker is NVRO and the CUSIP is 64157F103. A total of 182 filers reported holding NEVRO CORP in Q2 2022. The put-call ratio across all filers is 1.60 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,390,202 | -43.5% | 72,331 | -25.3% | 0.01% | -51.7% |
| Q2 2023 | $2,459,944 | +131167.0% | 96,772 | +86.7% | 0.03% | 0.0% |
| Q1 2023 | $1,874 | -31.8% | 51,839 | -25.3% | 0.03% | -46.3% |
| Q4 2022 | $2,748 | -98.7% | 69,382 | +1348.5% | 0.05% | +800.0% |
| Q2 2022 | $210,000 | -90.3% | 4,790 | -83.9% | 0.01% | -88.0% |
| Q1 2022 | $2,154,000 | +91.8% | 29,776 | +115.0% | 0.05% | +163.2% |
| Q4 2021 | $1,123,000 | +379.9% | 13,847 | +881.4% | 0.02% | +375.0% |
| Q2 2021 | $234,000 | -83.9% | 1,411 | -83.2% | 0.00% | -90.2% |
| Q4 2020 | $1,456,000 | +600.0% | 8,411 | +464.1% | 0.04% | +355.6% |
| Q3 2020 | $208,000 | -83.1% | 1,491 | -85.5% | 0.01% | -85.2% |
| Q2 2020 | $1,232,000 | +66.5% | 10,313 | +39.4% | 0.06% | -7.6% |
| Q1 2020 | $740,000 | +220.3% | 7,399 | +276.3% | 0.07% | +560.0% |
| Q4 2019 | $231,000 | -65.5% | 1,966 | -88.6% | 0.01% | -23.1% |
| Q4 2018 | $670,000 | -26.2% | 17,236 | +8.2% | 0.01% | -43.5% |
| Q3 2018 | $908,000 | +78.7% | 15,926 | +150.3% | 0.02% | +27.8% |
| Q2 2018 | $508,000 | -1.7% | 6,362 | +6.7% | 0.02% | +5.9% |
| Q1 2018 | $517,000 | +153.4% | 5,961 | +101.5% | 0.02% | +240.0% |
| Q4 2017 | $204,000 | -86.8% | 2,958 | -85.7% | 0.01% | -89.4% |
| Q2 2017 | $1,540,000 | +255.7% | 20,685 | +347.1% | 0.05% | +261.5% |
| Q1 2017 | $433,000 | -46.6% | 4,626 | -58.6% | 0.01% | -38.1% |
| Q4 2016 | $811,000 | -41.2% | 11,164 | -15.6% | 0.02% | -34.4% |
| Q3 2016 | $1,380,000 | +432.8% | 13,221 | +276.2% | 0.03% | +540.0% |
| Q2 2016 | $259,000 | -37.7% | 3,514 | -52.5% | 0.01% | -54.5% |
| Q1 2016 | $416,000 | -31.6% | 7,400 | -43.5% | 0.01% | -47.6% |
| Q3 2015 | $608,000 | – | 13,100 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tiger Eye Capital LLC | 239,122 | $41,392,000 | 8.25% |
| Integral Health Asset Management, LLC | 88,000 | $15,233,000 | 4.53% |
| Iron Triangle Partners LP | 168,761 | $29,213,000 | 3.79% |
| Eos Focused Equity Management, L.P. | 14,002 | $2,424,000 | 2.37% |
| PFM Health Sciences, LP | 311,940 | $53,997,000 | 1.90% |
| Perceptive Advisors | 977,565 | $169,217,000 | 1.82% |
| Rock Springs Capital Management LP | 395,000 | $68,375,000 | 1.45% |
| Lisanti Capital Growth, LLC | 54,302 | $9,400,000 | 1.30% |
| HealthCor Management, L.P. | 156,046 | $27,012,000 | 1.04% |
| FRED ALGER MANAGEMENT, LLC | 2,136,612 | $369,848,000 | 0.96% |